Compare Pfizer with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TTK HEALTHCARE - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TTK HEALTHCARE PFIZER/
TTK HEALTHCARE
 
P/E (TTM) x 48.7 10.7 456.0% View Chart
P/BV x 8.1 1.6 521.5% View Chart
Dividend Yield % 0.4 1.0 42.4%  

Financials

 PFIZER   TTK HEALTHCARE
EQUITY SHARE DATA
    PFIZER
Mar-19
TTK HEALTHCARE
Mar-19
PFIZER/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,8401,215 316.0%   
Low Rs2,080610 340.9%   
Sales per share (Unadj.) Rs455.0444.4 102.4%  
Earnings per share (Unadj.) Rs93.817.2 543.8%  
Cash flow per share (Unadj.) Rs109.427.6 395.9%  
Dividends per share (Unadj.) Rs22.505.00 450.0%  
Dividend yield (eoy) %0.80.5 138.7%  
Book value per share (Unadj.) Rs658.2177.9 369.9%  
Shares outstanding (eoy) m45.7514.13 323.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.52.1 316.8%   
Avg P/E ratio x31.652.9 59.7%  
P/CF ratio (eoy) x27.133.0 81.9%  
Price / Book Value ratio x4.55.1 87.7%  
Dividend payout %24.029.0 82.8%   
Avg Mkt Cap Rs m135,42012,894 1,050.2%   
No. of employees `0002.62.3 113.8%   
Total wages/salary Rs m3,2381,307 247.8%   
Avg. sales/employee Rs Th7,911.42,715.7 291.3%   
Avg. wages/employee Rs Th1,230.9565.3 217.7%   
Avg. net profit/employee Rs Th1,630.7105.4 1,547.1%   
INCOME DATA
Net Sales Rs m20,8156,279 331.5%  
Other income Rs m1,67478 2,159.9%   
Total revenues Rs m22,4896,356 353.8%   
Gross profit Rs m5,712496 1,152.5%  
Depreciation Rs m714147 486.6%   
Interest Rs m7334 215.7%   
Profit before tax Rs m6,599393 1,680.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309149 1,550.4%   
Profit after tax Rs m4,291244 1,760.6%  
Gross profit margin %27.47.9 347.7%  
Effective tax rate %35.037.9 92.2%   
Net profit margin %20.63.9 531.1%  
BALANCE SHEET DATA
Current assets Rs m27,1672,717 999.8%   
Current liabilities Rs m8,9171,571 567.7%   
Net working cap to sales %87.718.3 480.2%  
Current ratio x3.01.7 176.1%  
Inventory Days Days6832 210.9%  
Debtors Days Days3047 64.5%  
Net fixed assets Rs m8,862991 894.2%   
Share capital Rs m458141 323.8%   
"Free" reserves Rs m29,6562,373 1,249.7%   
Net worth Rs m30,1132,514 1,197.7%   
Long term debt Rs m253 735.3%   
Total assets Rs m39,4004,158 947.5%  
Interest coverage x91.512.6 725.5%   
Debt to equity ratio x00 61.4%  
Sales to assets ratio x0.51.5 35.0%   
Return on assets %11.16.7 165.9%  
Return on equity %14.29.7 147.0%  
Return on capital %22.116.9 130.7%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m428225 190.2%   
Fx outflow Rs m78671 1,105.9%   
Net fx Rs m-358154 -232.4%   
CASH FLOW
From Operations Rs m978173 565.0%  
From Investments Rs m35197 363.9%  
From Financial Activity Rs m-1,099-307 357.5%  
Net Cashflow Rs m231-38 -612.2%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 5.2 94.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 25.8 91.9%  
Shareholders   85,207 12,723 669.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUVEN LIFE SCIENCES  NEULAND LABS  PIRAMAL ENTERPRISES  FDC  SUN PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Dives Over 1,100 Points, Dow Futures Down by 119 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 1,148 points, down 2.4% at 47,683 levels.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 19, 2021 01:59 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS